you are viewing a single comment's thread.
The drug sector is not off to a poor start. A few of the major pharma/biotech ETF's from Dec.31 close to Feb1 close: IBB 137.22 - 147.77; BBH 53.50 - 58.64; XBI 87.91 - 96.05. AFFY's performance is an anomaly. Nevertheless, I am long here.